SUMO-1 modification of human cytomegalovirus IE1/IE72

Mary L. Spengler, Karen Kurapatwinski, Adrian R. Black, Jane Azizkhan-Clifford

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Human cytomegalovirus (HCMV) immediate-early protein IE1/IE72 is involved in undermining many cellular processes including cell cycle regulation, apoptosis, nuclear architecture, and gene expression. The multifunctional nature of IE72 suggests that posttranslational modifications may modulate its activities. IE72 is a phosphoprotein and has intrinsic kinase activity (S. Pajovic, E. L. Wong, A. R. Black, and J. C. Azizkhan, Mol. Cell. Biol. 17:6459-6464, 1997). We now demonstrate that IE72 is covalently conjugated to the small ubiquitin-like modifier (SUMO-1). SUMO-1 is an 11.5-kDa protein that is conjugated to multiple proteins and has been reported to exhibit multiple effects, including modulation of protein stability, subcellular localization, and gene expression. A covalently modified protein migrating at ∼92 kDa, which is stabilized by a SUMO-1 hydrolase inhibitor, is revealed by Western blotting with anti-IE72 of lysates from cells infected with HCMV or cells expressing IE72. SUMO modification of IE72 was confirmed by immunoprecipitation with anti-IE72 and anti-SUMO-1 followed by Western blotting with anti-SUMO-1 and anti-IE72, respectively. Lysine 450 is within a sumoylation consensus site (I,V,L)KXE; changing lysine 450 to arginine by point mutation abolishes SUMO-1 modification of IE72. Inhibition of protein phosphatase 1 and 2A, which increases the phosphorylation of IE72, suppresses the formation of SUMO-1-IE72 conjugates. Both wild-type IE72 and IE72K450R localize to nuclear PML oncogenic domains and disrupt them. Studies of protein stability, transactivation, and complementation of IE72-deficient HCMV (CR208) have revealed no significant differences between wild-type IE72 and IE72K450R.

Original languageEnglish (US)
Pages (from-to)2990-2996
Number of pages7
JournalJournal of virology
Volume76
Issue number6
DOIs
StatePublished - Mar 11 2002

Fingerprint

Human herpesvirus 5
Cytomegalovirus
Protein Stability
Lysine
Western Blotting
Sumoylation
Protein Phosphatase 1
Gene Expression
Protein Phosphatase 2
phosphoprotein phosphatase
Proteins
proteins
Phosphoproteins
Post Translational Protein Processing
Ubiquitin
Immunoprecipitation
Point Mutation
Transcriptional Activation
Arginine
lysine

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Spengler, M. L., Kurapatwinski, K., Black, A. R., & Azizkhan-Clifford, J. (2002). SUMO-1 modification of human cytomegalovirus IE1/IE72. Journal of virology, 76(6), 2990-2996. https://doi.org/10.1128/JVI.76.6.2990-2996.2002

SUMO-1 modification of human cytomegalovirus IE1/IE72. / Spengler, Mary L.; Kurapatwinski, Karen; Black, Adrian R.; Azizkhan-Clifford, Jane.

In: Journal of virology, Vol. 76, No. 6, 11.03.2002, p. 2990-2996.

Research output: Contribution to journalArticle

Spengler, ML, Kurapatwinski, K, Black, AR & Azizkhan-Clifford, J 2002, 'SUMO-1 modification of human cytomegalovirus IE1/IE72', Journal of virology, vol. 76, no. 6, pp. 2990-2996. https://doi.org/10.1128/JVI.76.6.2990-2996.2002
Spengler, Mary L. ; Kurapatwinski, Karen ; Black, Adrian R. ; Azizkhan-Clifford, Jane. / SUMO-1 modification of human cytomegalovirus IE1/IE72. In: Journal of virology. 2002 ; Vol. 76, No. 6. pp. 2990-2996.
@article{514620eb398a422e80ce35f992a56464,
title = "SUMO-1 modification of human cytomegalovirus IE1/IE72",
abstract = "Human cytomegalovirus (HCMV) immediate-early protein IE1/IE72 is involved in undermining many cellular processes including cell cycle regulation, apoptosis, nuclear architecture, and gene expression. The multifunctional nature of IE72 suggests that posttranslational modifications may modulate its activities. IE72 is a phosphoprotein and has intrinsic kinase activity (S. Pajovic, E. L. Wong, A. R. Black, and J. C. Azizkhan, Mol. Cell. Biol. 17:6459-6464, 1997). We now demonstrate that IE72 is covalently conjugated to the small ubiquitin-like modifier (SUMO-1). SUMO-1 is an 11.5-kDa protein that is conjugated to multiple proteins and has been reported to exhibit multiple effects, including modulation of protein stability, subcellular localization, and gene expression. A covalently modified protein migrating at ∼92 kDa, which is stabilized by a SUMO-1 hydrolase inhibitor, is revealed by Western blotting with anti-IE72 of lysates from cells infected with HCMV or cells expressing IE72. SUMO modification of IE72 was confirmed by immunoprecipitation with anti-IE72 and anti-SUMO-1 followed by Western blotting with anti-SUMO-1 and anti-IE72, respectively. Lysine 450 is within a sumoylation consensus site (I,V,L)KXE; changing lysine 450 to arginine by point mutation abolishes SUMO-1 modification of IE72. Inhibition of protein phosphatase 1 and 2A, which increases the phosphorylation of IE72, suppresses the formation of SUMO-1-IE72 conjugates. Both wild-type IE72 and IE72K450R localize to nuclear PML oncogenic domains and disrupt them. Studies of protein stability, transactivation, and complementation of IE72-deficient HCMV (CR208) have revealed no significant differences between wild-type IE72 and IE72K450R.",
author = "Spengler, {Mary L.} and Karen Kurapatwinski and Black, {Adrian R.} and Jane Azizkhan-Clifford",
year = "2002",
month = "3",
day = "11",
doi = "10.1128/JVI.76.6.2990-2996.2002",
language = "English (US)",
volume = "76",
pages = "2990--2996",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - SUMO-1 modification of human cytomegalovirus IE1/IE72

AU - Spengler, Mary L.

AU - Kurapatwinski, Karen

AU - Black, Adrian R.

AU - Azizkhan-Clifford, Jane

PY - 2002/3/11

Y1 - 2002/3/11

N2 - Human cytomegalovirus (HCMV) immediate-early protein IE1/IE72 is involved in undermining many cellular processes including cell cycle regulation, apoptosis, nuclear architecture, and gene expression. The multifunctional nature of IE72 suggests that posttranslational modifications may modulate its activities. IE72 is a phosphoprotein and has intrinsic kinase activity (S. Pajovic, E. L. Wong, A. R. Black, and J. C. Azizkhan, Mol. Cell. Biol. 17:6459-6464, 1997). We now demonstrate that IE72 is covalently conjugated to the small ubiquitin-like modifier (SUMO-1). SUMO-1 is an 11.5-kDa protein that is conjugated to multiple proteins and has been reported to exhibit multiple effects, including modulation of protein stability, subcellular localization, and gene expression. A covalently modified protein migrating at ∼92 kDa, which is stabilized by a SUMO-1 hydrolase inhibitor, is revealed by Western blotting with anti-IE72 of lysates from cells infected with HCMV or cells expressing IE72. SUMO modification of IE72 was confirmed by immunoprecipitation with anti-IE72 and anti-SUMO-1 followed by Western blotting with anti-SUMO-1 and anti-IE72, respectively. Lysine 450 is within a sumoylation consensus site (I,V,L)KXE; changing lysine 450 to arginine by point mutation abolishes SUMO-1 modification of IE72. Inhibition of protein phosphatase 1 and 2A, which increases the phosphorylation of IE72, suppresses the formation of SUMO-1-IE72 conjugates. Both wild-type IE72 and IE72K450R localize to nuclear PML oncogenic domains and disrupt them. Studies of protein stability, transactivation, and complementation of IE72-deficient HCMV (CR208) have revealed no significant differences between wild-type IE72 and IE72K450R.

AB - Human cytomegalovirus (HCMV) immediate-early protein IE1/IE72 is involved in undermining many cellular processes including cell cycle regulation, apoptosis, nuclear architecture, and gene expression. The multifunctional nature of IE72 suggests that posttranslational modifications may modulate its activities. IE72 is a phosphoprotein and has intrinsic kinase activity (S. Pajovic, E. L. Wong, A. R. Black, and J. C. Azizkhan, Mol. Cell. Biol. 17:6459-6464, 1997). We now demonstrate that IE72 is covalently conjugated to the small ubiquitin-like modifier (SUMO-1). SUMO-1 is an 11.5-kDa protein that is conjugated to multiple proteins and has been reported to exhibit multiple effects, including modulation of protein stability, subcellular localization, and gene expression. A covalently modified protein migrating at ∼92 kDa, which is stabilized by a SUMO-1 hydrolase inhibitor, is revealed by Western blotting with anti-IE72 of lysates from cells infected with HCMV or cells expressing IE72. SUMO modification of IE72 was confirmed by immunoprecipitation with anti-IE72 and anti-SUMO-1 followed by Western blotting with anti-SUMO-1 and anti-IE72, respectively. Lysine 450 is within a sumoylation consensus site (I,V,L)KXE; changing lysine 450 to arginine by point mutation abolishes SUMO-1 modification of IE72. Inhibition of protein phosphatase 1 and 2A, which increases the phosphorylation of IE72, suppresses the formation of SUMO-1-IE72 conjugates. Both wild-type IE72 and IE72K450R localize to nuclear PML oncogenic domains and disrupt them. Studies of protein stability, transactivation, and complementation of IE72-deficient HCMV (CR208) have revealed no significant differences between wild-type IE72 and IE72K450R.

UR - http://www.scopus.com/inward/record.url?scp=0036184785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036184785&partnerID=8YFLogxK

U2 - 10.1128/JVI.76.6.2990-2996.2002

DO - 10.1128/JVI.76.6.2990-2996.2002

M3 - Article

C2 - 11861864

AN - SCOPUS:0036184785

VL - 76

SP - 2990

EP - 2996

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

ER -